BRIEF-Bristol Myers says keen on deals of different sizes

Oct 24 (Reuters) - Bristol-Myers Squibb Co : * Company says interested in deals of different sizes, geared primarily toward products and technologies, rather than toward inversions * Company, in conference call with analysts, says "encouraged" by clincal trial data from "069" melanoma trial involving combo of its Yervoy and Opdivo immuno-oncology drugs * Company says has in-house data from "069" study, premature to disclose regulatory strategy for use of data